Contact Us

Effexor
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Date you stopped taking this drug:

Date you started taking this drug:

Name(s) of all antidepressants taken:

Age of patient when antidepressant(s) prescribed:

What condition was this medication prescribed to treat?

Did patient become violent while taking antidepressant(s)?

Was suicide attempted after taking antidepressant(s)?

Did attempted suicide result in death?

Was hospitalization or institutionalization required after taking antidepressant(s)?

If you have stopped taking Effexor, or have tried to stop taking Effexor, have you experienced withdrawal side effects?

Please further describe side effects:

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


Regulators Recommend Restricted Use of Drug

Dec 6, 2004 | AP

British regulators recommended on Monday that physicians restrict the use of the anti-depressant Efexor from drugmaker Wyeth because its use could have side effects for heart health and pose other potential risks that require more careful monitoring than other drugs in the class. Wyeth said it would challenge the decision, but its shares slipped 3 percent.

The United Kingdom's Medicines and Healthcare Products Regulatory Agency said the drug, which is marketed as Effexor in the United States, may cause irregular heart rhythms, withdrawal symptoms and have a higher rate of death from overdose than similar drugs.

The agency is recommending that only specialists should prescribe Efexor and that patients should be continually supervised. The drug should also not be prescribed to patients with heart problems, the agency said.

In a statement, Wyeth said it will challenge the agency's action and urged it to accept the company's previous recommendations for labeling, educational initiatives and new packaging to reduce the risk of suicide and overdose.

The anti-depressant is the Madison, N.J.-based pharmaceutical company's best-selling drug.


Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo